Generation of a RIP1 Knockout U937 Cell Line Using the CRISPR-Cas9 System

Area of Science:

• Molecular Biology
• Cell Biology
• Immunology

Background:

• The Receptor-Interacting Protein Kinase 1 (RIP1) is a critical mediator in programmed cell death pathways, including necroptosis.
• Understanding RIP1's role requires robust genetic tools to generate knockout cell lines for functional studies.

Purpose of the Study:

• To establish a reliable CRISPR/Cas9 protocol for RIP1 gene knockout in the human monocyte U937 cell line.
• To validate the functional consequences of RIP1 loss on cell death and mitochondrial activity.

Main Methods:

• Utilized CRISPR/Cas9 technology with specific guide RNA and lentiviral vectors for gene editing in U937 cells.
• Performed necroptosis induction assays and measured cell viability.
• Assessed mitochondrial reactive oxygen species (ROS) production using fluorescence microscopy.

Main Results:

• Successfully generated U937 cells with RIP1 gene knockout, confirmed by functional assays.
• RIP1 knockout cells exhibited significantly reduced cell death upon necroptosis induction.
• Knockout cells showed decreased mitochondrial ROS generation under necroptotic conditions.

Conclusions:

• The developed CRISPR/Cas9 protocol effectively inactivates the RIP1 gene in U937 cells.
• Loss of RIP1 function confers resistance to necroptosis and reduces associated mitochondrial ROS production.
• This method provides a valuable tool for studying RIP1-mediated cell death and can be adapted for other cell death regulators.